UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 62

Sortiert nach

Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings

The New England journal of medicine, 2021-10, Vol.385 (15), p.1355-1371

2021

Volltextzugriff (PDF)

Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022

MMWR. Morbidity and mortality weekly report, 2022-02, Vol.71 (7), p.255-263

2022

Volltextzugriff (PDF)

Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022

MMWR. Morbidity and mortality weekly report, 2022-01, Vol.71 (4), p.139-145

2022

Volltextzugriff (PDF)

Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022

MMWR. Morbidity and mortality weekly report, 2022-03, Vol.71 (9), p.352-358

2022

Volltextzugriff (PDF)

Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatients

BMC infectious diseases, 2022-11, Vol.22 (1), p.818-818, Article 818

2022

Volltextzugriff (PDF)

Dynamic-ETL: a hybrid approach for health data extraction, transformation and loading

BMC medical informatics and decision making, 2017-09, Vol.17 (1), p.134-134, Article 134

2017

Volltextzugriff (PDF)

Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022

MMWR. Morbidity and mortality weekly report, 2022-07, Vol.71 (29), p.931-939

2022

Volltextzugriff (PDF)

Real-World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients

The Journal of infectious diseases, 2022-12, Vol.226 (12), p.2129-2136

2022

Volltextzugriff (PDF)

Routine Emergency Department Screening to Decrease Subsequent Physical Abuse

Annals of emergency medicine, 2024-06

2024

Volltextzugriff (PDF)

A hybrid approach to record linkage using a combination of deterministic and probabilistic methodology

Journal of the American Medical Informatics Association : JAMIA, 2020-04, Vol.27 (4), p.505-513

2020

Volltextzugriff (PDF)

Real-World Evidence of Neutralizing Monoclonal Antibodies for Preventing Hospitalization and Mortality in COVID-19 Outpatients

Chest, 2023-05, Vol.163 (5), p.1061-1070

2023

Volltextzugriff (PDF)

1215-P: Evaluating Alternate Bias Correction Methods in Estimating Diabetes Prevalence with Electronic Health Records

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With Coronavirus Disease 2019—VISION Network, 10 States, June 2021–March 2023

Clinical infectious diseases, 2024-02

2024

Volltextzugriff (PDF)

Impact of accounting for correlation between COVID-19 and influenza vaccination in a COVID-19 vaccine effectiveness evaluation using a test-negative design

Vaccine, 2023-12, Vol.41 (51), p.7581-7586

2023

Volltextzugriff (PDF)

Effectiveness of BNT162b2 COVID-19 Vaccination in Children and Adolescents

Pediatrics (Evanston), 2023-05, Vol.151 (5)

2023

Volltextzugriff (PDF)

Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19—VISION Network, August 2021 to March 2022

The Journal of infectious diseases, 2023-04, Vol.227 (8), p.961-969

2023

Volltextzugriff (PDF)

Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19-VISION Network, 10 States, June 2021-March 2023

Clinical infectious diseases, 2024-02, Vol.78 (2), p.338-348

2024

Volltextzugriff (PDF)

Protection From COVID-19 mRNA Vaccination and Prior SARS-CoV-2 Infection Against COVID-19-Associated Encounters in Adults During Delta and Omicron Predominance

The Journal of infectious diseases, 2023-06, Vol.227 (12), p.1348-1363

2023

Volltextzugriff (PDF)

Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19-Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance - Nine States, June-August 2021

MMWR. Morbidity and mortality weekly report, 2021-09, Vol.70 (37), p.1291-1293

2021

Volltextzugriff (PDF)

Improving record linkage performance in the presence of missing linkage data

Journal of biomedical informatics, 2014-12, Vol.52, p.43-54

2014

Volltextzugriff (PDF)

Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19–Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions — VISION Network, September 2022–April 2023

American journal of transplantation, 2023-07, Vol.23 (7), p.1062-1076

2023

Volltextzugriff (PDF)

Engaging Patients and Other Stakeholders in “Designing for Dissemination” of Record Linkage Methods and Tools

Applied clinical informatics, 2023-08, Vol.14 (4), p.670-683

2023

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(61)

Publikationsform

Sprache

Englisch
(62)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(46)
Life Sciences & Biomedicine
(45)
Humans
(35)
Hospitalization
(32)
Covid-19
(30)
Adult
(26)
Covid-19 Vaccines
(25)
Covid-19 - Prevention & Control
(22)
Severe Acute Respiratory Syndrome Coronavirus 2
(22)
Vaccine Efficacy
(21)
Vaccines
(20)
Vaccination
(19)
Adolescent
(18)
Coronaviruses
(18)
Adults
(16)
Covid-19 - Epidemiology
(16)
Hospitals
(16)
Mrna
(16)
Mrna Vaccines
(16)
Public Health
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings

Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022

Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022

Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022

Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatients

Dynamic-ETL: a hybrid approach for health data extraction, transformation and loading

Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022

Real-World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients

Routine Emergency Department Screening to Decrease Subsequent Physical Abuse

A hybrid approach to record linkage using a combination of deterministic and probabilistic methodology

Real-World Evidence of Neutralizing Monoclonal Antibodies for Preventing Hospitalization and Mortality in COVID-19 Outpatients

Vaccine Effectiveness Against Pediatric Influenza-A–Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022–2023 Season: VISION Network

Influenza Vaccine Effectiveness Against Influenza A–Associated Emergency Department, Urgent Care, and Hospitalization Encounters Among US Adults, 2022–2023

1215-P: Evaluating Alternate Bias Correction Methods in Estimating Diabetes Prevalence with Electronic Health Records

Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With Coronavirus Disease 2019—VISION Network, 10 States, June 2021–March 2023

Impact of accounting for correlation between COVID-19 and influenza vaccination in a COVID-19 vaccine effectiveness evaluation using a test-negative design

Effectiveness of BNT162b2 COVID-19 Vaccination in Children and Adolescents

Vaccine Effectiveness Against Influenza-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2021–2022 Season, VISION Network

Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19—VISION Network, August 2021 to March 2022

Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19-VISION Network, 10 States, June 2021-March 2023

Protection From COVID-19 mRNA Vaccination and Prior SARS-CoV-2 Infection Against COVID-19-Associated Encounters in Adults During Delta and Omicron Predominance

Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19-Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance - Nine States, June-August 2021

Improving record linkage performance in the presence of missing linkage data

Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19–Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions — VISION Network, September 2022–April 2023

Engaging Patients and Other Stakeholders in “Designing for Dissemination” of Record Linkage Methods and Tools

Suchergebnisse filtern